Related Experiment Video
Updated: Jun 9, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression
Gabriele Gaggero1, Michela Campora2, Davide Taietti3
1IRCCS Ospedale Policlinico San Martino, Pathology Unit, Genoa, Italy.
Abstract:
Lymphoplasmacyte-rich meningioma (LPRM) is one of the rarest variants of grade I meningiomas. It can be clinically associated with prominent peripheral blood abnormalities, anemia, and/or various gammopathy, which usually disappear after surgical removal of the tumor. We document a case of right frontal LPRM in a 72-year-old male who presented general cognitive decadence. The patient suffered from mild anemia. The LPRM is a rare variant of meningioma, with only a few cases globally reported in the literature. It has been categorized as a grade I tumor in the 2021 World Health Organization (WHO) classification central nervous system. Due to the rarity, this meningioma variant origin and biological behavior are still not clear. Immunohistochemistry profile showed prominent PD-L1 expression, leading to additional interrogation on LPRM immunomorphological characteristics, the significance of the inflammatory tumoral microenvironment and its correlation with the immune-checkpoints.
Insights
Lymphoplasmacyte-rich meningioma (LPRM) is a rare grade I tumor. This case highlights its association with anemia and cognitive decline, offering insights into its immune microenvironment.
Area of Science:
- Neuropathology
- Oncology
- Immunology
Background:
- Lymphoplasmacyte-rich meningioma (LPRM) is an exceptionally rare variant of grade I meningioma.
- LPRM can present with significant peripheral blood abnormalities, including anemia and gammopathy, often resolving post-surgery.
- The rarity of LPRM limits understanding of its origins and behavior.
Purpose of the Study:
- To document a case of right frontal LPRM in an elderly male presenting with cognitive decline and mild anemia.
- To investigate the immunomorphological characteristics of LPRM, focusing on PD-L1 expression.
- To explore the role of the inflammatory tumor microenvironment and immune checkpoints in LPRM.
Main Methods:
- Case report of a 72-year-old male with right frontal LPRM.
- Clinical assessment including evaluation of cognitive function and peripheral blood counts.
- Immunohistochemical analysis to determine the tumor's cellular composition and PD-L1 expression profile.
Main Results:
- The patient presented with general cognitive decadence and mild anemia.
- Immunohistochemistry revealed prominent PD-L1 expression in the LPRM.
- The findings suggest a potential link between the inflammatory microenvironment, PD-L1 expression, and immune checkpoint activity in LPRM.
Conclusions:
- LPRM, though rare, can be associated with systemic effects like anemia and neurological symptoms.
- Prominent PD-L1 expression in LPRM warrants further investigation into its immunobiology.
- Understanding the immune microenvironment of LPRM may offer new therapeutic avenues.
Related Concept Videos
Abnormal Proliferation
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology

